Hetero Labs Ltd, an Indian drug manufacturing company had got approval from authorities to launch its version of anti-viral drug favipiravir for the treatment of COVID-19.The drug will be available on medical shops from Wednesday. The medicine is priced at Rs. 59 per tablet. The drug, is approved to treat mild to moderate COVID-19.
Favipiravir was originally developed by Japan’s Fujifilm Holdings Corp under the brand name Avigan for treating influenza. Hetero is also among the drug-makers that have a license with US-based Gilead Sciences Inc to make remdesivir.
Other Indian drug makers developing or selling favipiravir include Glenmark Pharmaceuticals Ltd, Cipla Ltd, privately held Brinton Pharma and Jenburkt Pharmaceuticals Ltd.
Post Your Comments